...
Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Ann Rheum Dis. 2005;64(Suppl 2):ii65–ii73ii65–ii68.
3 The RS Domain Model
3.1 Assumptions for the RS Domain Model
...
Dataset wrap |
---|
|
Rowcaps |
---|
Rows 1-16: | Show the symptom and area responses for the baseline visit. | Rows 17-29: | Show the subscores and total scores for the baseline visit. | Rows 30-59: | Show the subject was not evaluated on this instrument at visit 2. Since the reason for not completing the visit was collected, the date is included in RSDTC for when the visit was planned. |
|
Dataset2 |
---|
Row | STUDYID | DOMAIN | USUBJID | RSSEQ | RSTESTCD | RSTEST | RSCAT | RSORRES | RSSTRESC | RSSTRESN | RSSTAT | RSREASND | RSLOBXFL | VISITNUM | RSDTC |
---|
1 | STUDYX | RS | 2324-P0001 | 1 | PASI0201 | PASI02-Head: Erythema/Redness
| PASI V2 | Slight | 1 | 1 |
|
| Y | 1 | 2015-05-15 | 2 | STUDYX | RS | 2324-P0001 | 2 | PASI0202 | PASI02-Head: Thickness/Induration
| PASI V2 | None | 0 | 0 |
|
| Y | 1 | 2015-05-15 | 3 | STUDYX | RS | 2324-P0001 | 3 | PASI0203 | PASI02-Head: Desquamation/Scaling
| PASI V2 | None | 0 | 0 |
|
| Y | 1 | 2015-05-15 | 4 | STUDYX | RS | 2324-P0001 | 4 | PASI0204 | PASI02-Head: Area Score
| PASI V2 | 1% - 9%<10% | 1 | 1 |
|
| Y | 1 | 2015-05-15 | 5 | STUDYX | RS | 2324-P0001 | 5 | PASI0205 | PASI02-Up Extrem: Erythema/Redness
| PASI V2 | Mild | 2 | 2 |
|
| Y | 1 | 2015-05-15 | 6 | STUDYX | RS | 2324-P0001 | 6 | PASI0206 | PASI02-Up Extrem: Thickness/Induration
| PASI V2 | Slight | 1 | 1 |
|
| Y | 1 | 2015-05-15 | 7 | STUDYX | RS | 2324-P0001 | 7 | PASI0207 | PASI02-Up Extrem: Desquamation/Scaling
| PASI V2 | Mild | 2 | 2 |
|
| Y | 1 | 2015-05-15 | 8 | STUDYX | RS | 2324-P0001 | 8 | PASI0208 | PASI02-Up Extrem: Area Score
| PASI V2 | 30% 30 - 49%<50% | 3 | 3 |
|
| Y | 1 | 2015-05-15 | 9 | STUDYX | RS | 2324-P0001 | 9 | PASI0209 | PASI02-Trunk: Erythema/Redness
| PASI V2 | None | 0 | 0 |
|
| Y | 1 | 2015-05-15 | 10 | STUDYX | RS | 2324-P0001 | 10 | PASI0210 | PASI02-Trunk: Thickness/Induration
| PASI V2 | None | 0 | 0 |
|
| Y | 1 | 2015-05-15 | 11 | STUDYX | RS | 2324-P0001 | 11 | PASI0211 | PASI02-Trunk: Desquamation/Scaling
| PASI V2 | None | 0 | 0 |
|
| Y | 1 | 2015-05-15 | 12 | STUDYX | RS | 2324-P0001 | 12 | PASI0212 | PASI02-Trunk: Area Score
| PASI V2 | No InvolvmentInvolvement | 0 | 0 |
|
| Y | 1 | 2015-05-15 | 13 | STUDYX | RS | 2324-P0001 | 13 | PASI0213 | PASI02-Low Extrem: Erythema/Redness
| PASI V2 | Slight | 1 | 1 |
|
| Y | 1 | 2015-05-15 | 14 | STUDYX | RS | 2324-P0001 | 14 | PASI0214 | PASI02-Low Extrem: Thickness/Induration
| PASI V2 | Slight | 1 | 1 |
|
| Y | 1 | 2015-05-15 | 15 | STUDYX | RS | 2324-P0001 | 15 | PASI0215 | PASI02-Low Extrem: Desquamation/Scaling
| PASI V2 | Slight | 1 | 1 |
|
| Y | 1 | 2015-05-15 | 16 | STUDYX | RS | 2324-P0001 | 16 | PASI0216 | PASI02-Low Extrem: Area Score
| PASI V2 | 10% 10 - 29%30% | 121 | 2 |
|
| Y | 1 | 2015-05-15 | 17 | STUDYX | RS | 2324-P0001 | 17 | PASI0217 | PASI02-Head: Sum of Symptom Scores
| PASI V2 | 1 | 1 | 1 |
|
| Y | 1 | 2015-05-15 | 18 | STUDYX | RS | 2324-P0001 | 18 | PASI0218 | PASI02-Head: Sum X Area
| PASI V2 | 1 | 1 | 1 |
|
| Y | 1 | 2015-05-15 | 19 | STUDYX | RS | 2324-P0001 | 19 | PASI0219 | PASI02-Head: Sum X Area X 0.1
| PASI V2 | 0.1 | 0.1 | 0.1 |
|
| Y | 1 | 2015-05-15 | 20 | STUDYX | RS | 2324-P0001 | 20 | PASI0220 | PASI02-Up Extrem: Sum of Symptom Scores
| PASI V2 | 5 | 5 | 5 |
|
| Y | 1 | 2015-05-15 | 21 | STUDYX | RS | 2324-P0001 | 21 | PASI0221 | PASI02-Up Extrem: Sum X Area
| PASI V2 | 15 | 15 | 15 |
|
| Y | 1 | 2015-05-15 | 22 | STUDYX | RS | 2324-P0001 | 22 | PASI0222 | PASI02-Up Extrem: Sum X Area X 0.2
| PASI V2 | 3 | 3 | 3 |
|
| Y | 1 | 2015-05-15 | 23 | STUDYX | RS | 2324-P0001 | 23 | PASI0223 | PASI02-Trunk: Sum of Symptom Scores
| PASI V2 | 0 | 0 | 0 |
|
| Y | 1 | 2015-05-15 | 24 | STUDYX | RS | 2324-P0001 | 24 | PASI0224 | PASI02-Trunk: Sum X Area
| PASI V2 | 0 | 0 | 0 |
|
| Y | 1 | 2015-05-15 | 25 | STUDYX | RS | 2324-P0001 | 25 | PASI0225 | PASI02-Trunk: Sum X Area X 0.3
| PASI V2 | 0 | 0 | 0 |
|
| Y | 1 | 2015-05-15 | 26 | STUDYX | RS | 2324-P0001 | 26 | PASI0226 | PASI02-Low Extrem: Sum of Symptom Scores
| PASI V2 | 3 | 3 | 3 |
|
| Y | 1 | 2015-05-15 | 27 | STUDYX | RS | 2324-P0001 | 27 | PASI0227 | PASI02-Low Extrem: Sum X Area
| PASI V2 | 363 | 6 | 36 |
|
| Y | 1 | 2015-05-15 | 28 | STUDYX | RS | 2324-P0001 | 28 | PASI0228 | PASI02-Low Extrem: Sum X Area X 0.4
| PASI V2 | 12.4 | 2.4 | 1.21.24 |
|
| Y | 1 | 2015-05-15 | 29 | STUDYX | RS | 2324-P0001 | 29 | PASI0229 | PASI02-Total Sum
| PASI V2 | 45.354 | 5.354 | 5.35 |
|
| Y | 1 | 2015-05-15 | 30 | STUDYX | RS | 2324-P0001 | 30 | PASI0201 | PASI02-Head: Erythema/Redness
| PASI V2 |
|
|
| NOT DONE | REFUSED |
| 2 | 2015-06-14 | 31 | STUDYX | RS | 2324-P0001 | 31 | PASI0202 | PASI02-Head: Thickness/Induration
| PASI V2 |
|
|
| NOT DONE | REFUSED |
| 2 | 2015-06-14 | 32 | STUDYX | RS | 2324-P0001 | 32 | PASI0203 | PASI02-Head: Desquamation/Scaling
| PASI V2 |
|
|
| NOT DONE | REFUSED |
| 2 | 2015-06-14 | ... |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 59 | STUDYX | RS | 2324-P0001 | 59 | PASI0229 | PASI02-Total Sum
| PASI V2 |
|
|
| NOT DONE | REFUSED |
| 2 | 2015-06-14 |
|
|
...